Helen Toledano

5.0k total citations
51 papers, 513 citations indexed

About

Helen Toledano is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Helen Toledano has authored 51 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 16 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Helen Toledano's work include Glioma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (10 papers) and Neurofibromatosis and Schwannoma Cases (10 papers). Helen Toledano is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (10 papers) and Neurofibromatosis and Schwannoma Cases (10 papers). Helen Toledano collaborates with scholars based in Israel, United States and Canada. Helen Toledano's co-authors include Shalom Michowiz, Nitza Goldenberg‐Cohen, Isaac Yaniv, Ian J. Cohen, Moshe Snir, Shifra Ash, Omer Bialer, Dani Bercovich, Smadar Avigad and Yael Goldberg and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Journal of neurosurgery.

In The Last Decade

Helen Toledano

47 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Toledano Israel 15 143 131 130 103 84 51 513
Ali H. Alassiri Saudi Arabia 12 125 0.9× 121 0.9× 135 1.0× 122 1.2× 47 0.6× 40 649
Wafik Zaky United States 12 110 0.8× 200 1.5× 271 2.1× 57 0.6× 38 0.5× 66 461
Anna Clerico Italy 16 202 1.4× 222 1.7× 74 0.6× 63 0.6× 105 1.3× 35 590
Wolfgang Krupp Germany 17 180 1.3× 250 1.9× 160 1.2× 82 0.8× 101 1.2× 38 784
Antonella Cacchione Italy 15 267 1.9× 174 1.3× 345 2.7× 43 0.4× 66 0.8× 64 685
Valérie Larouche Canada 12 240 1.7× 333 2.5× 328 2.5× 131 1.3× 47 0.6× 38 639
Muh‐Lii Liang Taiwan 16 165 1.2× 303 2.3× 378 2.9× 102 1.0× 145 1.7× 53 844
Léa Guerrini‐Rousseau France 13 170 1.2× 231 1.8× 308 2.4× 54 0.5× 97 1.2× 40 585
Mohamed S Abdelbaki United States 12 113 0.8× 137 1.0× 191 1.5× 38 0.4× 43 0.5× 64 528
Edward Kachur Canada 12 145 1.0× 49 0.4× 249 1.9× 94 0.9× 58 0.7× 25 624

Countries citing papers authored by Helen Toledano

Since Specialization
Citations

This map shows the geographic impact of Helen Toledano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Toledano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Toledano more than expected).

Fields of papers citing papers by Helen Toledano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Toledano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Toledano. The network helps show where Helen Toledano may publish in the future.

Co-authorship network of co-authors of Helen Toledano

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Toledano. A scholar is included among the top collaborators of Helen Toledano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Toledano. Helen Toledano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Trippett, Tanya, Helen Toledano, Quentin Campbell Hewson, et al.. (2022). Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study. Targeted Oncology. 17(3). 283–293. 30 indexed citations
3.
Toledano, Helen, et al.. (2022). Optic pathway glioma and endocrine disorders in patients with and without NF1. Pediatric Research. 93(1). 233–241. 8 indexed citations
4.
Michaeli, Orli, Ayelet Erez, Shai Izraeli, et al.. (2021). Di‐genic inheritance of germline POLE and PMS2 pathogenic variants causes a unique condition associated with pediatric cancer predisposition. Clinical Genetics. 101(4). 442–447. 10 indexed citations
5.
Toescu, Sebastian, Noa Schwartz, Amir Kershenovich, et al.. (2021). Postoperative hydrocephalus management may cause delays in adjuvant treatment following paediatric posterior fossa tumour resection: a multicentre retrospective observational study. Child s Nervous System. 38(2). 311–317. 7 indexed citations
6.
Elitzur, Sarah, Assaf Arie Barg, Gil Gilad, et al.. (2021). Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic. International Journal of Clinical Oncology. 26(8). 1569–1574. 18 indexed citations
7.
Renzi, Samuele, Orli Michaeli, S.P. Hector, et al.. (2020). Bevacizumab for NF2‐associated vestibular schwannomas of childhood and adolescence. Pediatric Blood & Cancer. 67(5). e28228–e28228. 21 indexed citations
8.
Zahavi, Alon, et al.. (2020). Proptosis due to intraorbital space-occupying lesions in children. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(11). 2541–2550. 1 indexed citations
9.
Goldberg, Yael, Rony Cohen, Rivka Friedland, et al.. (2019). The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex. Clinical Genetics. 97(2). 296–304. 6 indexed citations
10.
Ash, Shifra, et al.. (2019). Likelihood of Diagnosing Neuroblastoma in Isolated Horner Syndrome. Journal of Neuro-Ophthalmology. 39(3). 308–312. 6 indexed citations
11.
12.
Toledano, Helen, et al.. (2018). MicroRNA–mRNA expression profiles associated with medulloblastoma subgroup 4. Cancer Management and Research. Volume 10. 339–352. 11 indexed citations
13.
Goldenberg‐Cohen, Nitza, et al.. (2017). Primary tumors underlying unilateral orbital proptosis in children. Investigative Ophthalmology & Visual Science. 58(8). 2418–2418. 1 indexed citations
14.
Konen, Osnat, et al.. (2017). Preferential sites of metastatic relapse on MRI of initially localized ependymoma in children. Clinical Imaging. 44. 12–15. 3 indexed citations
15.
Michowiz, Shalom, Helen Toledano, Avraham Hirshberg, et al.. (2017). Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with Medulloblastoma. Scientific Reports. 7(1). 3648–3648. 25 indexed citations
16.
Ash, Shifra, Helen Toledano, Yehuda Kollender, et al.. (2015). Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89). Cancer Chemotherapy and Pharmacology. 76(5). 909–916. 9 indexed citations
17.
Bialer, Omer, Nitza Goldenberg‐Cohen, Helen Toledano, Moshe Snir, & Shalom Michowiz. (2013). Retinal NFL thinning on OCT correlates with visual field loss in pediatric craniopharyngioma. Canadian Journal of Ophthalmology. 48(6). 494–499. 30 indexed citations
18.
Laviv, Yosef, et al.. (2012). BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low‐grade glioma. FEBS Open Bio. 2(1). 129–134. 11 indexed citations
19.
Goldenberg‐Cohen, Nitza, Liora Kornreich, Helen Toledano, et al.. (2010). Long-Term Ophthalmological Follow-Up of Children with Parinaud Syndrome. Ophthalmic surgery, lasers & imaging retina. 41(4). 467–471. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali H. Alassiri Breakdown of academic impact, for papers by Wafik Zaky Breakdown of academic impact, for papers by Anna Clerico Breakdown of academic impact, for papers by Wolfgang Krupp Breakdown of academic impact, for papers by Antonella Cacchione Breakdown of academic impact, for papers by Valérie Larouche Breakdown of academic impact, for papers by Muh‐Lii Liang Breakdown of academic impact, for papers by Léa Guerrini‐Rousseau Breakdown of academic impact, for papers by Mohamed S Abdelbaki Breakdown of academic impact, for papers by Edward Kachur
Rankless by CCL
2026